Literature DB >> 17879571

Long-term follow-up on the effect of silastic ring vertical gastroplasty on weight and co-morbidities.

Haim Paran1, Liat Shargian, Ivan Shwartz, Mordechai Gutman.   

Abstract

BACKGROUND: Silastic ring vertical gastroplasty (SRVG) is a simple, effective and reproducible restrictive operation for the treatment of morbid obesity. Over the last years, it has lost its popularity due to the development of adjustable gastric banding systems performed laparoscopically. In order to evaluate the long-term effect of SRVG on weight loss and co-morbidities, we reviewed the results of SRVG operations in our institution.
METHODS: We reviewed SRVG operations performed in our University-affiliated General Hospital. Data was collected from the patients' in-patient records, their outpatient-clinic files, and from a telephone interview.
RESULTS: Between 1989 and 2001, 162 patients were operated upon. Complete follow-up was obtained of 115 patients (71%). The mean follow-up was 7.1 +/- 3 years (range 4 to 16 years). Mean preoperative BMI was 47 kg/m2 (range 34 to 69 kg/m2). Maximal weight loss was obtained within 1 year to a mean BMI of 29 kg/m2, with a mean excess BMI loss of 67%. Subsequently, there was a small increase in BMI, which stabilized at 34 kg/m2 up to 15 years after the operation. A rapid, significant improvement in obesity-related co-morbidities was observed regarding hypertension (81%), diabetes (100%), sleep disorders (90%), osteoarthritis (83%) and ischemic heart disease (75%). There was no peri-operative mortality. Early complication rate was 10%. Late complications included postoperative ventral hernia (18%), esophagitis (31%), ring stricture (19%), ring erosion (2 patients), failure of staple line (8%) and obstruction of the pouch with food (19%). 35 patients (30%) required another procedure, 8 of them were eventually converted to other bariatric operations, and 2 patients had the ring removed and refused another bariatric procedure. The overall satisfaction rate was 86%.
CONCLUSIONS: SRVG is a simple, safe and effective bariatric operation in selected patients with morbid obesity. It results in a rapid, excellent effect on obesity-related co-morbidities and good long-term effect in weight loss, which compares positively with other, more complicated bariatric operations.

Entities:  

Mesh:

Year:  2007        PMID: 17879571     DOI: 10.1007/s11695-007-9136-9

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  15 in total

Review 1.  Surgery for obesity: panacea or Pandora's box?

Authors:  Rahul Pannala; Mark Kidd; Irvin M Modlin
Journal:  Dig Surg       Date:  2006-04-20       Impact factor: 2.588

Review 2.  Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review.

Authors:  Andrew E Chapman; George Kiroff; Philip Game; Bruce Foster; Paul O'Brien; John Ham; Guy J Maddern
Journal:  Surgery       Date:  2004-03       Impact factor: 3.982

Review 3.  Review: long-term impact of bariatric surgery on body weight, comorbidities, and nutritional status.

Authors:  Meena Shah; Vinaya Simha; Abhimanyu Garg
Journal:  J Clin Endocrinol Metab       Date:  2006-09-05       Impact factor: 5.958

Review 4.  Reporting weight loss 2007.

Authors:  Mervyn Deitel; Khaled Gawdat; John Melissas
Journal:  Obes Surg       Date:  2007-05       Impact factor: 4.129

5.  A 10-year experience with laparoscopic gastric banding for morbid obesity: high long-term complication and failure rates.

Authors:  M Suter; J M Calmes; A Paroz; V Giusti
Journal:  Obes Surg       Date:  2006-07       Impact factor: 4.129

6.  Vertical banded gastroplasty for obesity.

Authors:  E E Mason
Journal:  Arch Surg       Date:  1982-05

7.  Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs.

Authors:  N T Nguyen; C Goldman; C J Rosenquist; A Arango; C J Cole; S J Lee; B M Wolfe
Journal:  Ann Surg       Date:  2001-09       Impact factor: 12.969

8.  Laparoscopic adjustable gastric banding: weight loss, co-morbidities, medication usage and quality of life at one year.

Authors:  Jessie H Ahroni; Kevin F Montgomery; Brad M Watkins
Journal:  Obes Surg       Date:  2005-05       Impact factor: 4.129

9.  Impact of gastric bypass operation on survival: a population-based analysis.

Authors:  David R Flum; E Patchen Dellinger
Journal:  J Am Coll Surg       Date:  2004-10       Impact factor: 6.113

10.  Long-term follow-up and factors influencing success of silastic ring vertical gastroplasty.

Authors:  Tal H Vishne; Edward Ramadan; Dan Alper; Ziona Avraham; Dan Seror; Zeev Dreznik
Journal:  Dig Surg       Date:  2004-03-23       Impact factor: 2.588

View more
  5 in total

1.  Perioperative outcomes of revisional laparoscopic gastric bypass after failed adjustable gastric banding and after vertical banded gastroplasty: experience with 107 cases and subgroup analysis.

Authors:  J A Apers; C Wens; V van Vlodrop; M Michiels; R Ceulemans; G van Daele; I Jacobs
Journal:  Surg Endosc       Date:  2012-09-26       Impact factor: 4.584

2.  Weight loss outcome after silastic ring Roux-en-Y gastric bypass: 8 years of follow-up.

Authors:  Antonio Carlos Valezi; Jorge Mali Junior; Mariano Almeida de Menezes; Edivaldo Macedo de Brito; Shirley A F de Souza
Journal:  Obes Surg       Date:  2010-11       Impact factor: 4.129

3.  Isolated food intolerance after adjustable gastric banding: a major cause of long-term band removal.

Authors:  Jérôme Dargent
Journal:  Obes Surg       Date:  2008-05-06       Impact factor: 4.129

4.  Changes in blood lipid levels following silastic ring vertical gastroplasty.

Authors:  Edward Ram; Tali Vishne; Abraham Magazanik; Gideon Harel; Aliza Zaidman; Gil Ohana; Yefim Rabinovich; Zeev Dreznik
Journal:  Obes Surg       Date:  2007-10       Impact factor: 4.129

5.  Lap banding as a redo surgery: "restriction over restriction" may be a relevant bariatric strategy.

Authors:  Jérôme Dargent
Journal:  Obes Surg       Date:  2009-06-09       Impact factor: 4.129

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.